ACADIA Pharmaceuticals Inc. (ACAD)
NASDAQ: ACAD · Real-Time Price · USD
15.94
+0.26 (1.66%)
Aug 23, 2024, 4:00 PM EDT - Market closed
ACADIA Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Revenue | 890.53 | 726.44 | 517.24 | 484.15 | 441.76 | 339.08 | Upgrade
|
| Revenue Growth (YoY) | 61.65% | 40.45% | 6.83% | 9.60% | 30.28% | 51.50% | Upgrade
|
| Cost of Revenue | 433.31 | 393.26 | 371.74 | 258.56 | 286.88 | 259.98 | Upgrade
|
| Gross Profit | 457.23 | 333.18 | 145.49 | 225.59 | 154.88 | 79.09 | Upgrade
|
| Selling, General & Admin | 434.41 | 406.56 | 369.09 | 396.03 | 388.66 | 325.64 | Upgrade
|
| Operating Expenses | 434.41 | 406.56 | 369.09 | 396.03 | 388.66 | 325.64 | Upgrade
|
| Operating Income | 22.82 | -73.38 | -223.6 | -170.44 | -233.79 | -246.55 | Upgrade
|
| Interest & Investment Income | 20.75 | 17.23 | 6.61 | 0.59 | 6.61 | 11.17 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.93 | - | - | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | 40.64 | -56.15 | -216.99 | -169.85 | -227.18 | -235.38 | Upgrade
|
| Merger & Restructuring Charges | - | - | - | - | -52.8 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | 5.11 | 5.11 | 3.54 | 2.33 | -1 | 1 | Upgrade
|
| Pretax Income | 45.74 | -51.04 | -213.44 | -167.52 | -280.97 | -234.38 | Upgrade
|
| Income Tax Expense | 15.18 | 10.25 | 2.53 | 0.35 | 0.61 | 0.88 | Upgrade
|
| Net Income | 30.57 | -61.29 | -215.98 | -167.87 | -281.58 | -235.26 | Upgrade
|
| Net Income to Common | 30.57 | -61.29 | -215.98 | -167.87 | -281.58 | -235.26 | Upgrade
|
| Shares Outstanding (Basic) | 165 | 164 | 162 | 160 | 157 | 147 | Upgrade
|
| Shares Outstanding (Diluted) | 165 | 164 | 162 | 160 | 157 | 147 | Upgrade
|
| Shares Change (YoY) | 1.81% | 1.32% | 0.74% | 2.01% | 6.88% | 16.29% | Upgrade
|
| EPS (Basic) | 0.19 | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | Upgrade
|
| EPS (Diluted) | 0.19 | -0.37 | -1.34 | -1.05 | -1.79 | -1.60 | Upgrade
|
| Free Cash Flow | 80.48 | 16.65 | -114.04 | -126.78 | -143.75 | -152.26 | Upgrade
|
| Free Cash Flow Per Share | 0.49 | 0.10 | -0.71 | -0.79 | -0.91 | -1.03 | Upgrade
|
| Gross Margin | 51.34% | 45.86% | 28.13% | 46.60% | 35.06% | 23.33% | Upgrade
|
| Operating Margin | 2.56% | -10.10% | -43.23% | -35.20% | -52.92% | -72.71% | Upgrade
|
| Profit Margin | 3.43% | -8.44% | -41.76% | -34.67% | -63.74% | -69.38% | Upgrade
|
| Free Cash Flow Margin | 9.04% | 2.29% | -22.05% | -26.19% | -32.54% | -44.90% | Upgrade
|
| EBITDA | 34.27 | -67.83 | -221.57 | -167.1 | -230.85 | -243.78 | Upgrade
|
| EBITDA Margin | 3.85% | -9.34% | -42.84% | -34.51% | -52.26% | -71.89% | Upgrade
|
| D&A For EBITDA | 11.46 | 5.55 | 2.03 | 3.34 | 2.93 | 2.77 | Upgrade
|
| EBIT | 22.82 | -73.38 | -223.6 | -170.44 | -233.79 | -246.55 | Upgrade
|
| EBIT Margin | 2.56% | -10.10% | -43.23% | -35.20% | -52.92% | -72.71% | Upgrade
|
| Effective Tax Rate | 33.18% | - | - | - | - | - | Upgrade
|
| Revenue as Reported | 890.53 | 726.44 | 517.24 | 484.15 | 441.76 | 339.08 | Upgrade
|
| Advertising Expenses | - | 9.4 | 5.5 | 41.8 | 51.1 | 38.3 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.